MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis
The MDM2 oncogene is overexpressed in 5–10% of human tumours. Its major physiological role is to inhibit the tumour suppressor p53. However, MDM2 has p53-independent effects on differentiation and does not predispose to tumorigenesis when it is expressed in the granular layer of the epidermis. These...
Gorde:
| Argitaratua izan da: | EMBO J |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group
2000
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC302089/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11013216/ https://ncbi.nlm.nih.govhttps://doi.org/10.1093/emboj/19.19.5135 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|